Victor P. Ghidu, Ph.D.

Associate

Victor P. Ghidu, Ph.D., serves intellectual property (IP) clients in patent matters, including drafting and prosecuting patent applications, assessing patentability and freedom to operate, and due diligence for various transactions and SEC filings. Victor's practice spans an array of technologies pertaining to the chemical and biotechnology arts, including small molecule drugs, natural product conjugates, biologics, medicinal formulations, specialty chemicals and formulations, polymers, organic light emitting diodes, fiber optics, and medical devices.

Extended Profile

Before joining Morgan Lewis, Victor practiced patent law at a boutique IP firm in the greater Philadelphia area. Victor brings to his practice a wealth of experience as a research scientist in organic and medicinal chemistry, but also as a technical sales specialist for a large multinational specialty chemicals corporation earlier in his career. Victor is fluent in Romanian.

Victor has co-authored several publications (selected: Ghidu et al., “A new and efficient synthetic route for the anxiolytic agent CL285032” Bioorg. Med. Chem. Lett., 2011, 21(1), 259-261; Ghidu et al., “Combined Chemical and Biosynthetic Route to Access a New Apoptolidin Congener” Org. Lett., 2009, 11 (14), 3032-3034; Ghidu et al., “Synthesis and Evaluation of the Cytotoxicity of Apoptolidinones A and D” J. Org. Chem., 2008, 73 (13), 4949-4955; Pearson and Ghidu, “A New Paradigm for Cationic Cyclization of Iron Tricarbonyl Diene Complexes with Pendant Alkenes and Arenes” Org. Lett., 2002, 4 (23), 4069-4071).

Victor is credited as a co-inventor on two patent applications of which one was recently granted a US Patent: US 10,131,637 (WO 2014/150395), and WO 2015/054117.